Omeros | OMER - Trade Creditors


Omeros reported $8.84M in Trade Creditors for its fiscal quarter ending in June of 2025.





Trade Creditors Change Date
Adma Biologics USD 20.52M 2M Mar/2026
Alnylam Pharmaceuticals USD 126.63M 10.91M Mar/2026
BioMarin Pharmaceutical USD 793.15M 34.12M Mar/2026
Cytokinetics USD 24.71M 80.91M Mar/2026
Gilead Sciences USD 645M 70M Mar/2026
Heron Therapeutics USD 8.97M 24K Mar/2026
Immunic USD 11.01M 873K Mar/2026
Insmed USD 73.38M 6.53M Mar/2026
Knight Therapeutics CAD 125.76M 7.63M Dec/2025
MacroGenics USD 4.29M 500K Mar/2026
Omeros USD 8.84M 4.42M Jun/2025
Pacira USD 14.01M 1.14M Mar/2026
Pfizer USD 4.51B 734M Mar/2026
Rockwell Medical USD 1.5M 423K Jun/2025
Sangamo BioSciences USD 10.74M 7.46M Jun/2025
Sarepta Therapeutics USD 70.38M 210.46M Mar/2026
United Therapeutics USD 498.3M 491.2M Mar/2026
Vertex Pharmaceuticals USD 3.47B 40.6M Mar/2026
Xoma USD 2.65M 1.52M Sep/2025